![Krishna R. Polu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Krishna R. Polu
No más puestos en curso
Perfil
Krishna R.
Polu was the founder of Expedition Therapeutics, Inc., founded in 2017, where the title held was Chief Executive Officer from 2017 to 2018.
Dr. Polu is also the founder of Lassen Therapeutics LLC,R1 Therapeutics, Inc...
Dr. Polu currently holds the position of Principal at Red Tree Venture Capital since 2021.
Former positions include Chief Executive Officer at Scout Bio, Inc. in 2018; Chief Executive Officer at Commit Biologics ApS from 2023 to 2025; Executive Director-Global Development at Amgen, Inc. from 2007 to 2009; Director at Goldilocks Therapeutics, Inc.; Independent Director at Frazier Lifesciences Acquisition Corp.; Vice President-Clinical Development at Affymax, Inc. from 2009 to 2013; Chief Medical Officer at CytomX Therapeutics Holdings LLC from 2013 to 2014; Chief Medical Officer at Horizon Pharmaceutical LLC from 2015 to 2016; Chief Medical Officer at Raptor Pharmaceuticals, Inc. from 2015 to 2016; Chief Medical Officer at CytomX Therapeutics, Inc. from 2013 to 2014; and Chief Medical Officer, EVP-Research & Development at Equillium, Inc. in 2020.
Education includes undergraduate studies at Stanford University and a doctorate from Texas University of Health Center at San Antonio.
Cargos activos de Krishna R. Polu
| Empresas | Cargo | Inicio |
|---|---|---|
Red Tree Venture Capital
 Red Tree Venture Capital Investment ManagersFinance Red Tree Venture Capital seeks investment opportunities in companies located in the US. The firm targets companies operating in the fields of life science innovation sectors. It provides financing for early stage capital requirements. | Inversor de Capital Privado | 01/01/2021 |
Antiguos cargos conocidos de Krishna R. Polu.
| Empresas | Cargo | Fin |
|---|---|---|
Commit Biologics
 Commit Biologics Miscellaneous Commercial ServicesCommercial Services Develops novel platform technology and therapeutics to treat cancer & autoimmune diseases | Director Ejecutivo | 28/01/2025 |
| EQUILLIUM, INC. | Director Técnico/Científico/I+D | 31/12/2020 |
Scout Bio, Inc.
 Scout Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that specializes in veterinary, animal health and gene therapy | Director Ejecutivo | 01/08/2018 |
Expedition Therapeutics, Inc.
 Expedition Therapeutics, Inc. BiotechnologyHealth Technology Develops treatments for inflammatory and respiratory diseases | Director Ejecutivo | 01/08/2018 |
| RAPTOR PHARMACEUTICAL CORP | Director Técnico/Científico/I+D | 01/12/2016 |
Formación de Krishna R. Polu.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
59
Relaciones de 1er grado
16
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 16 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Affymax, Inc.
 Affymax, Inc. BiotechnologyHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Texas University of Health Center at San Antonio
 Texas University of Health Center at San Antonio Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CytomX Therapeutics Holdings LLC
 CytomX Therapeutics Holdings LLC Pharmaceuticals: MajorHealth Technology Engaged in the development of new generation targeted antibody therapeutics | Health Technology |
Horizon Pharmaceutical LLC
 Horizon Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of life-altering therapeutics that treat debilitating and often fatal diseases | Health Technology |
Raptor Pharmaceuticals, Inc.
 Raptor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and markets life-altering therapeutics | Health Technology |
CytomX Therapeutics, Inc.
 CytomX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer | Health Technology |
Scout Bio, Inc.
Scout Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that specializes in veterinary, animal health and gene therapy | Health Technology |
Equillium, Inc.
 Equillium, Inc. BiotechnologyHealth Technology Engages in the development of products for severe immune-inflammatory disorders | Health Technology |
Expedition Therapeutics, Inc.
Expedition Therapeutics, Inc. BiotechnologyHealth Technology Develops treatments for inflammatory and respiratory diseases | Health Technology |
Lassen Therapeutics LLC
 Lassen Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage company that develops and manufactures therapeutic antibody products | Commercial Services |
Goldilocks Therapeutics, Inc.
 Goldilocks Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops drug delivery technology for kidney tubules | Commercial Services |
Red Tree Venture Capital
Red Tree Venture Capital Investment ManagersFinance Red Tree Venture Capital seeks investment opportunities in companies located in the US. The firm targets companies operating in the fields of life science innovation sectors. It provides financing for early stage capital requirements. | Finance |
Frazier Lifesciences Acquisition Corp.
 Frazier Lifesciences Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Commit Biologics
Commit Biologics Miscellaneous Commercial ServicesCommercial Services Develops novel platform technology and therapeutics to treat cancer & autoimmune diseases | Commercial Services |
- Bolsa de valores
- Insiders
- Krishna R. Polu
